Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Healthtrust
AstraZeneca
Covington
Medtronic
US Army
Julphar
Queensland Health
Cantor Fitzgerald

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,424,471

« Back to Dashboard

Summary for Patent: 5,424,471
Title: Crystalline amifostine compositions and methods of the preparation and use of same
Abstract:The present invention relates to a sterile, stable vacuum dried crystalline amifostine composition and, optionally, pharmaceutically acceptable excipient(s). Typically, the crystalline compositions of the present invention exhibit enhanced stability at temperatures ranging from about 4.degree. C. to about ambient temperature for a period of at least 2 years relative to existing solid vacuum dried amorphous amifostine preparations. The reconstituted compositions of the present invention are suitable for administration to humans as a radio- or chemoprotecting agent.
Inventor(s): Kennedy; Paul E. (Phoenixville, PA), Rajewski; Roger A. (Lawrence, KS), Baldoni; John M. (Glenmore, PA)
Assignee: U.S. Bioscience, Inc. (West Conshohocken, PA)
Application Number:08/099,298
Patent Claim Types:
see list of patent claims
Composition; Process; Formulation; Use; Dosage form;

Drugs Protected by US Patent 5,424,471

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,424,471

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Finland 950420 ➤ Sign Up
Spain 2215992 ➤ Sign Up
European Patent Office 1764103 ➤ Sign Up
Czech Republic 9500230 ➤ Sign Up
Germany 69333453 ➤ Sign Up
Denmark 0655917 ➤ Sign Up
European Patent Office 0655917 ➤ Sign Up
European Patent Office 1243272 ➤ Sign Up
Czech Republic 284417 ➤ Sign Up
China 1307870 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Covington
UBS
Colorcon
Express Scripts
Merck
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot